Haleon plc (ETR:H6D0)

Market Cap	44.38B
Revenue (ttm)	13.58B
Net Income (ttm)	1.74B
Shares Out	n/a
EPS (ttm)	0.19
PE Ratio	25.45
Forward PE	21.70
Dividend	0.08 (1.55%)
Ex-Dividend Date	Apr 24, 2025

Volume	n/a
Average Volume	2,532
Open	4.951
Previous Close	4.958
Day's Range	4.951 - 4.984
52-Week Range	3.785 - 5.112
Beta	n/a
RSI	66.26
Earnings Date	Jul 31, 2025

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprisi...

• Industry: Pharmaceutical Preparations
• Founded: 1715
• Employees: 24,561
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: H6D0

Financial Performance

In 2024, Haleon's revenue was 11.23 billion, a decrease of -0.61% compared to the previous year's 11.30 billion. Earnings were 1.44 billion, an increase of 37.46%.

Financial numbers in GBP